[go: up one dir, main page]

MX2021000323A - Enzimas de variante de pantotenato quinasa modificadas geneticamente. - Google Patents

Enzimas de variante de pantotenato quinasa modificadas geneticamente.

Info

Publication number
MX2021000323A
MX2021000323A MX2021000323A MX2021000323A MX2021000323A MX 2021000323 A MX2021000323 A MX 2021000323A MX 2021000323 A MX2021000323 A MX 2021000323A MX 2021000323 A MX2021000323 A MX 2021000323A MX 2021000323 A MX2021000323 A MX 2021000323A
Authority
MX
Mexico
Prior art keywords
enzymes
pank
pantothenate kinase
present
engineered pantothenate
Prior art date
Application number
MX2021000323A
Other languages
English (en)
Inventor
Oscar Alvizo
Nandhitha Subramanian
Agustina Rodriguez-Granillo
Grant Murphy
Margie Tabuga Borra-Garske
Lillian Jasmine Miller
Jessie B Slaton
Aksiniya Lyubenova Petkova
Joshua Kolev
Anna Fryszkowska
Original Assignee
Codexis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Codexis Inc filed Critical Codexis Inc
Publication of MX2021000323A publication Critical patent/MX2021000323A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y207/00Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/01Phosphotransferases with an alcohol group as acceptor (2.7.1)
    • C12Y207/01033Pantothenate kinase (2.7.1.33)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención proporciona enzimas pantotenato quinasa (PanK) modificadas genéticamente, polipéptidos que tienen actividad PanK y polinucleótidos que codifican estas enzimas, así como vectores y células hospederas que comprenden estos polinucleótidos y polipéptidos; también se proporcionan métodos para producir enzimas PanK; la presente invención proporciona además composiciones que comprenden las enzimas PanK y métodos para usar las enzimas PanK modificadas genéticamente; la presente invención encuentra un uso particular en la producción de compuestos farmacéuticos.
MX2021000323A 2018-07-09 2019-07-02 Enzimas de variante de pantotenato quinasa modificadas geneticamente. MX2021000323A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862695587P 2018-07-09 2018-07-09
US201962822301P 2019-03-22 2019-03-22
PCT/US2019/040379 WO2020014050A1 (en) 2018-07-09 2019-07-02 Engineered pantothenate kinase variant enzymes

Publications (1)

Publication Number Publication Date
MX2021000323A true MX2021000323A (es) 2021-03-25

Family

ID=69101223

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021000323A MX2021000323A (es) 2018-07-09 2019-07-02 Enzimas de variante de pantotenato quinasa modificadas geneticamente.

Country Status (11)

Country Link
US (3) US10889806B2 (es)
EP (1) EP3820991A4 (es)
JP (1) JP7491588B2 (es)
KR (1) KR20210031929A (es)
CN (1) CN112673091B (es)
AU (1) AU2019300838B2 (es)
CA (1) CA3103819A1 (es)
IL (1) IL279884B1 (es)
MX (1) MX2021000323A (es)
SG (1) SG11202012136YA (es)
WO (1) WO2020014050A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7773906B2 (ja) 2018-07-09 2025-11-20 メルク・シャープ・アンド・ドーム・エルエルシー 4’-エチルヌクレオシド類似体の酵素的合成
JP7491588B2 (ja) * 2018-07-09 2024-05-28 コデクシス, インコーポレイテッド 操作されたパントテン酸キナーゼ改変体酵素
BR112021024819A2 (pt) * 2019-07-02 2022-01-25 Codexis Inc Acetato quinase engenheirada, composição, sequência de polinucleotídeos, vetor de expressão, célula hospedeira, e, método de produção de uma acetato quinase engenheirada
CA3196603A1 (en) * 2020-10-02 2022-04-07 Codexis, Inc. Engineered pantothenate kinase variant enzymes
IL305928A (en) 2021-04-02 2023-11-01 Codexis Inc Transgenic enzymes of acetate kinase variant
WO2025179109A1 (en) * 2024-02-22 2025-08-28 Invizyne Technologies, Inc. In vitro synthesis of coenzyme a and acetyl-coa for cell-free biocatalysis

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6165793A (en) 1996-03-25 2000-12-26 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6309883B1 (en) 1994-02-17 2001-10-30 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5834252A (en) 1995-04-18 1998-11-10 Glaxo Group Limited End-complementary polymerase reaction
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US5928905A (en) 1995-04-18 1999-07-27 Glaxo Group Limited End-complementary polymerase reaction
US20060257890A1 (en) 1996-05-20 2006-11-16 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US6395547B1 (en) 1994-02-17 2002-05-28 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6406855B1 (en) 1994-02-17 2002-06-18 Maxygen, Inc. Methods and compositions for polypeptide engineering
US6995017B1 (en) 1994-02-17 2006-02-07 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
AU694954B2 (en) 1994-06-03 1998-08-06 Novo Nordisk A/S Purified myceliophthora laccases and nucleic acids encoding same
ATE294871T1 (de) 1994-06-30 2005-05-15 Novozymes Biotech Inc Nicht-toxisches, nicht-toxigenes, nicht- pathogenes fusarium expressionssystem und darin zu verwendende promotoren und terminatoren
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
US6506602B1 (en) 1996-03-25 2003-01-14 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6096548A (en) 1996-03-25 2000-08-01 Maxygen, Inc. Method for directing evolution of a virus
CA2276064C (en) 1997-01-17 2013-12-17 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
US7148054B2 (en) 1997-01-17 2006-12-12 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
US6265201B1 (en) 1997-01-17 2001-07-24 Regents Of The University Of Minnesota DNA molecules and protein displaying improved triazine compound degrading ability
US6326204B1 (en) 1997-01-17 2001-12-04 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
EP2270234B1 (en) 1997-12-08 2013-03-06 California Institute of Technology Method for creating polynucleotide and polypeptide sequences
KR20010034731A (ko) 1998-04-02 2001-04-25 텔루스 제너틱 리소시즈, 인크. 유전자 서열 중에 유전자 병변이 있는 식물을 얻는 방법
CN1314911A (zh) 1998-05-01 2001-09-26 麦克西根股份有限公司 用dna改组优化害虫抗性基因
WO1999065927A2 (en) 1998-06-17 1999-12-23 Maxygen, Inc. Method for producing polynucleotides with desired properties
US6365408B1 (en) 1998-06-19 2002-04-02 Maxygen, Inc. Methods of evolving a polynucleotides by mutagenesis and recombination
US6605430B1 (en) 1998-08-12 2003-08-12 Maxygen, Inc. DNA shuffling of monooxygenase genes for production of industrial chemicals
CA2345203A1 (en) 1998-10-07 2000-04-13 Maxygen Inc. Dna shuffling to produce nucleic acids for mycotoxin detoxification
WO2000028018A1 (en) 1998-11-10 2000-05-18 Maxygen, Inc. Modified adp-glucose pyrophosphorylase for improvement and optimization of plant phenotypes
JP4221100B2 (ja) 1999-01-13 2009-02-12 エルピーダメモリ株式会社 半導体装置
US6368861B1 (en) 1999-01-19 2002-04-09 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6917882B2 (en) 1999-01-19 2005-07-12 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US6436675B1 (en) 1999-09-28 2002-08-20 Maxygen, Inc. Use of codon-varied oligonucleotide synthesis for synthetic shuffling
US6376246B1 (en) 1999-02-05 2002-04-23 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US7024312B1 (en) 1999-01-19 2006-04-04 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US20070065838A1 (en) 1999-01-19 2007-03-22 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US7873477B1 (en) 2001-08-21 2011-01-18 Codexis Mayflower Holdings, Llc Method and system using systematically varied data libraries
AU3210100A (en) 1999-01-19 2000-08-01 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US7702464B1 (en) 2001-08-21 2010-04-20 Maxygen, Inc. Method and apparatus for codon determining
US6961664B2 (en) 1999-01-19 2005-11-01 Maxygen Methods of populating data structures for use in evolutionary simulations
US8457903B1 (en) 1999-01-19 2013-06-04 Codexis Mayflower Holdings, Llc Method and/or apparatus for determining codons
IL144657A0 (en) 1999-02-11 2002-06-30 Maxygen Inc High throughput mass spectrometry
AU3719500A (en) 1999-03-05 2000-09-21 Maxygen, Inc. Recombination of insertion modified nucleic acids
US6703240B1 (en) 1999-04-13 2004-03-09 Maxygar, Inc. Modified starch metabolism enzymes and encoding genes for improvement and optimization of plant phenotypes
KR20020092912A (ko) * 1999-09-21 2002-12-12 바스프 악티엔게젤샤프트 판토-화합물의 생산을 위한 방법 및 미생물
US7430477B2 (en) 1999-10-12 2008-09-30 Maxygen, Inc. Methods of populating data structures for use in evolutionary simulations
US6519065B1 (en) 1999-11-05 2003-02-11 Jds Fitel Inc. Chromatic dispersion compensation device
US6686515B1 (en) 1999-11-23 2004-02-03 Maxygen, Inc. Homologous recombination in plants
SG121902A1 (en) 2000-01-11 2006-05-26 Maxygen Inc Integrated systems for diversity generation and screening
WO2001075767A2 (en) 2000-03-30 2001-10-11 Maxygen, Inc. In silico cross-over site selection
DE60144145D1 (de) 2000-04-03 2011-04-14 Maxygen Inc Subtilisin-variante
US20050084907A1 (en) 2002-03-01 2005-04-21 Maxygen, Inc. Methods, systems, and software for identifying functional biomolecules
US7747391B2 (en) 2002-03-01 2010-06-29 Maxygen, Inc. Methods, systems, and software for identifying functional biomolecules
HUE028524T2 (en) 2002-03-01 2016-12-28 Codexis Mayflower Holdings Llc Procedures, systems and software for identifying functional biomolecules
EP1488335A4 (en) 2002-03-09 2006-11-15 Maxygen Inc OPTIMIZING CROSSOVER POINTS FOR THE ADJUSTED EVOLUTION
DK2250595T3 (en) 2008-02-12 2017-09-04 Codexis Inc PROCEDURE FOR SELECTING AN OPTIMIZED VARIETY OF VARIETIES
WO2009102901A1 (en) 2008-02-12 2009-08-20 Codexis, Inc. Method of generating an optimized, diverse population of variants
CA2726850C (en) 2008-06-13 2015-06-02 Codexis, Inc. Method of synthesizing polynucleotide variants
US20090312196A1 (en) 2008-06-13 2009-12-17 Codexis, Inc. Method of synthesizing polynucleotide variants
US8383346B2 (en) 2008-06-13 2013-02-26 Codexis, Inc. Combined automated parallel synthesis of polynucleotide variants
US8609396B2 (en) * 2009-08-28 2013-12-17 Cj Cheiljedang Corporation Microorganism producing O-acetyl-homoserine and the method of producing O-acetyl-homoserine using the microorganism
NO2657250T3 (es) * 2010-12-21 2018-02-03
EP2726651B1 (en) 2011-06-28 2018-11-07 Codexis, Inc. Protein variant generation by region shuffling
WO2013159055A1 (en) 2012-04-20 2013-10-24 Codexis, Inc. Production of fatty alcohols from engineered microorganisms
JP7491588B2 (ja) * 2018-07-09 2024-05-28 コデクシス, インコーポレイテッド 操作されたパントテン酸キナーゼ改変体酵素

Also Published As

Publication number Publication date
WO2020014050A1 (en) 2020-01-16
JP7491588B2 (ja) 2024-05-28
JP2021530216A (ja) 2021-11-11
CA3103819A1 (en) 2020-01-16
US20240425827A1 (en) 2024-12-26
US12110513B2 (en) 2024-10-08
EP3820991A1 (en) 2021-05-19
US20200010815A1 (en) 2020-01-09
AU2019300838B2 (en) 2025-05-29
KR20210031929A (ko) 2021-03-23
EP3820991A4 (en) 2022-07-06
CN112673091A (zh) 2021-04-16
IL279884A (en) 2021-03-01
AU2019300838A1 (en) 2021-01-07
US10889806B2 (en) 2021-01-12
SG11202012136YA (en) 2021-01-28
US20210102179A1 (en) 2021-04-08
CN112673091B (zh) 2025-04-25
IL279884B1 (en) 2025-12-01

Similar Documents

Publication Publication Date Title
MX2021000327A (es) Enzimas de variante de fosforilasa de nucleosido de purina modificadas geneticamente.
MX2021000323A (es) Enzimas de variante de pantotenato quinasa modificadas geneticamente.
MX2025005375A (es) Variantes de desoxirribonucleasa (dnasa)
AU2017380488A8 (en) Polypeptides having lysozyme activity, polynucleotides encoding same and uses and compositions thereof
EP3957723A3 (en) Engineered ligase variants
MX2021000328A (es) Enzimas de variantes de galactosa oxidasa modificadas geneticamente.
EP3950941A3 (en) Dnase polypeptide variants
PH12019500709A1 (en) Anti-lag-3 antibodies and methods of use thereof
PH12014502767A1 (en) Interleukin-2 fusion proteins and uses thereof
MX2021015613A (es) Enzimas variantes acetato cinasa dise?adas.
MX2019012223A (es) Anticuerpos anti-cd137 y metodos de uso de los mismos.
MY198233A (en) Protease-Activated T Cell Bispecific Molecules
MX2017014125A (es) Variantes de alfa-amilasa y polinucleotidos que codifican las mismas.
WO2016066756A3 (en) Protease variants and polynucleotides encoding same
WO2016066757A3 (en) Protease variants and polynucleotides encoding same
MX2019000140A (es) Variantes de xilanasa y polinucleotidos que las codifican.
EP4477734A3 (en) Protease variants and polynucleotides encoding same
EP4219702A3 (en) Enzyme variants and polynucleotides encoding the same
MX2009010207A (es) Peptidos de hidrazido como inhibidores de proteasa ns3 de virus de hepatitis c.
ZA202102469B (en) Engineered dna polymerase variants
AU2018264463A1 (en) Polypeptides having lysozyme activity, polynucleotides encoding same and uses and compositions thereof
MX2019014889A (es) Polipeptidos que tienen actividad trehalasa y polinucleotidos que los codifican.
EP4603591A3 (en) Polypeptides having d-psicose 3-epimerase activity and polynucleotides encoding same
MX2022005119A (es) Metodos de reduccion de olor.
EP4570894A3 (en) Mannanase variants and polynucleotides encoding same